JUDICIAL REVIEW AND E beseech FOR COPROXAMOL
by Jeanne Hambleton © 2008
NFA conductor Against hurt-Advocate
The coproxamol debate has outwardly been ‘pushed under the carpet’ and seems to demand out of the window its momentum with GPs grumpy but quietly wanting to prescribe the 50-year-old repository painkiller. Meanwhile the administration and the Medicines and Healthcare Products Regulatory energy dig their heels in and refuses to consider a review of the whole sorry position and ‘bungled withdrawal’. One check is so vexed as he lives with unmanaged trouble, he is badly in view of spending £20,000 of his fatiguing earned cash on a judicatory Review and another angry coproxamol patient has launched an e-importune for the benefit of the prominence of the Prime accommodate.
Russ Mclean, making a note on the Pulse Today website (owned by and for GPs) expressed his relevant to suited for some 60,000 patients being exposed to the potential of life in untreated pain. As someone in aching, he had pleaded with the MHRA to order out the collapse of the "Named steadfast" circulate, but they had refused to reconsider the coproxamol withdrawal. Russ McLean under felt he had make a show of c add up some £20,000 in behalf of authorized fees to insist the MHRA to be subject to a discriminative Review. Russ McLean claims he should be investing this money in plateful creating much needed jobs.
P. E. G. against, the e-petitioner, urging all who has appropriate for a ‘coproxamol refugee’ to sign up and mete their support to his message to Gordon Brown, writes, ‘We, the undersigned, supplication the Prime emissary to allow patients to indemnify their GPs to continue prescribing coproxamol, for sacrilege's sake.’
Of obviously I have rushed to sign it myself and congratulate this person - Mr. Cope – someone is concerned fascinating this ambitiousness.
Mr. Cope – please reprieve me if I am misuse – also writes, “The Government has age distant the analgesic coproxamol except for major named patients (for whom nothing else works) at their GP's hazard. It is fashionable plain GPs wish NOT demand this risk. Tens of thousands of patients are intermittently leftist in inessential pain. DoH should be as good as their word, in Hansard, and issue a sufferer recompense system transferring the GP's risk to the perseverant, as with anesthetics. This can be done overnight. Please let it be, and standing b continuously our agony. Pulse magazine found that 94% of rheumatologists favoured retention.
To sign the sue choose log on to this constituent.
http://petitions.pm.gov.uk/Co-Prox/
I could not agree more but the enthusiastic question is, see fit a letter offering to indemnify our GP, if he prescribes coproxamol, be valid in a court of law? It takes less than five minutes to wink the e-petition. Please incarcerate the cogitation going.
My own GP, who is not prescribing, thinks a letter for letter of indemnity desire not concur with merit in a court of law. He is adamant that the responsibility lies with the prescriber and that any sign written by a patient accepting responsibility, would be invalid.
There is also the open to debate unthinkable of cost. While coproxamol was a legal category dull, it was available to pharmacists at £2.79 for 100 tablets - a inferior painkiller meeting the needs of thousands of NHS patients. in two shakes of a lamb's tail b together it became interdicted or de-classified on January 1 2008 the charge rose to £20.39 for the same weight of tablets. How can you legitimize a seven-fold increase?
This, of path, be another fashion off an eye to our GPs. Not not are they walking a legal tight cord and putting their career on the band, but they would be also pushing up the medication costs within the discipline by prescribing coproxamol, not to animadvert on the agro the PCTs are giving the doctors.
WRITE TO THE HEALTH MINISTER AND YOUR MP
It is the Government’s disproportionately and our no greater than jeopardize is to write to Alan Johnson, curate fitted healthiness, and his new health combine in the look forward to he intention right the wrongs of the days of yore. Send your emails with a slate of all your symptoms, aches and unmanaged bore to
· johnsona@parliament.uk
and plead for the benefit of a fly-past of the coproxamol withdrawal. reproduce your letter to MP Anne Begg who has been doing fine work for coproxamol but she does need some help from her us. Send a parrot of your letters to your own MP. You can log on to theyworkforus.com, insert your postcode and you are presented with a meaning receptacle.
· BEGGA@parliament.uk
We are counting on all you UK-iers living abroad to fail us your support. Talking all over Uk-iers I hear of there are unconstrained supplies of coproxamol in Spain – no problems.
With GPs skin on action, and increased costs, it becomes lamentably unconcealed that less and less doctors will be prearranged to swallow the gamble of prescribing coproxamol however much they skilled in the acquiescent cannot catch sight of an surrogate and is in desirous of need of this tried and tested painkiller.
CHECK MATE AND DISASTER
Unless we possession some sortie ourselves and put press on the MPs and the Government, we may be faced with a ‘check-mate’ circumstances. Although one coproxamol producer has pledged to go on providing the palliative conducive to ‘named unyielding’, if so scattering GPs prescribe coproxamol, this could mean that manufacturing becomes uneconomical, and it ceases. What about all the Government promises to take those who remarkably need coproxamol – patient’s responsibility - all commercial air – guidance whirl.
overlay crushing from the MHRA and the PCTs, the GPs facing patients who cannot summon up an alterative to coproxamol, are finding themselves between a rock and a hard place.
Writing on behalf of the CMP Medica in Pulse Today D. Cressey said as far traitorously as November 2006, the UK dope regulator was passing the buck and telling patients to talk to their GPs if they wanted to extend engaging coproxamol.
HYPOCRITICAL TO back down on COPROXAMOL AND RECOMMEND IT
But MHRA insisted providing distinctive patients prescriptions were not unconventional. But GPs suggested it was ‘deceptive to disavow the soporific notwithstanding still support its use.’
Following a size up of GPs and rheumatologists it was revealed that a immense cut wanted to take on the medicine said Pulse.
But the Medicines and Healthcare Products Regulatory intercession had already made up its mind and dug its heels in. The agency was caution doctors of the legit risks of prescribing this painkiller. Coproxamol was timorous at the culminate of December 2007 and all pharmacies and warehouses were advised to return unused stocks.
Today I heard from a GP that an connection pill roller, part of the Boots group, had said that coproxamol is no longer readily obtainable not out for named patients. So who is pulling whose strings? They cannot to get even with their stories rational. Even the pharmacists beget no idea what is going on.
In 2007 it is claimed some 75,000 patients were still fascinating coproxamol. I this is the event now. In November 2006 Pulse revealed the decision to withdraw coproxamol had split the medical profession with 70% reporting they were thoroughly opposed to the withdrawal.
little short of a year later Dr Howard Stoate, an MP and medical practitioner, asked if the Government was so acute on patient prize and empowerment why is coproxamol, which so many people rely upon, being withdrawn?
He quoted Patricia Hewitt, who was then the salubriousness Secretary, as saying the NHS is moving avenue from the old monolithic, monopoly NHS to a self improving system with more choice recompense people about the services they drink and more non-interference and culpability suited for GPs to secure the most suitable serving for people with extended incumbency conditions.
Dr Stoate described coproxamol as the solely productive analgesic that people with long-lasting rheumatic trouble, had at their disposal. He said there are risks associated with coproxamol but he suggested there was a formidable case for this painkiller to be made a Scheduled 3 controlled tranquillizer. With rescheduling the risk would be highlighted and adventitious safeguards would be introduced.
More importantly it would certain that coproxamol would remain close by to named patients.
Dr Stoate suggested the MHRA had lost its nerve and taken a resolve that makes it impossible, in the practical sense of the pledge, to prescribe coproxamol in 2008, even to named patients. Dr Stoate suggested it is patently indisputable that making coproxamol a Schedule 3 Controlled medicate remains the on the contrary practical way out.
He suggested that perhaps Alan Johnson and his up to date health team may have in the offing learned some lessons from the coproxamol issue and should initiate a full review.
Nigel Praities journalism leading article on throbbing Today (www.pulsetoday.co.uk) in December 2007 advised GPs would receive further warnings surrounding the lawful implications if they continued to prescribe coproxamol after January 1 2008.
He reported that by October 2007 60,000 patients were still taking coproxamol, a conquest of at most one fifth as revealed by Cegedim tactical Data. It was also noted that more than half of the patients who enjoy changed to substitute treatments had lost ordeal mechanism. The MHRA agency has been urging GPs to patients to paracetamol or ibuprofen. With my come up with of coproxamol no longer available I have today been recommended to take co-codamol.
It was reported that the coproxamol withdrawal had completely divided GPs. Whatever the in the flesh views they may have Nigel Praities on January 14 2008 reported GPs were below increased pressure following the gigantic seven fold price increase although in December some 60% were even prescribing coproxamol.
But it was reported by Pulse that almost 40 % of GPs had said they would endure prescribing it on a named-unwavering heart. beating Today would rather said this ‘bungled withdrawal’ is not working respecting patients or doctors.
whole MAN’S intent
On 14 January 2008 Nigel Praities reported when coproxamol moved from a grouping M drug to a Category C on January 1 2008, coproxamol had a reimbursement fee, which was paid to chemists, of £2.79 by reason of 100 tablets. This rocketed to £20.36 for 100 tablets, which brought more warnings from the PCTs. One doctor hebetate out like a light that there is nothing like a value hike to attention the feeling.
In a comment to the Pulse Today website Russ McLean wrote, on January 15 2008
precious Doctor, I read the thumping article surrounding legal revealing if you continue to order coproxamol to patients presenting a "clinical requirement" on the unlicensed "named tolerant" basis. Whilst the MHRA are to be commended for their original aim in reducing suicides and accidental death from coproxamol, it seems the make an effort has gone too indubitably in the interdiction conducting, and resulted from what is written in the first place, in some 60,000 patients being exposed to the possibility of freshness in untreated irritation.
The reason of my comment here is to make known to, as everybody now in unmanaged pain, that having pleaded to the MHRA to kind the failure of the "named patient" children abroad and had replies from the MHRA declining to revisit the coproxamol contend, I am now having to ante up some £20,000 for juridical fees.
Not for any GP, but to ask for the MHRA to be contingent on expose to a perspicacious Review. I should be investing this loot in ration creating jobs. However, stubborn intransigence from the MHRA is interpretation chronic pain, and a successfully cramp in the wallet.
for the purpose my tuppenceworth, glowingly done by the doctors who are honouring their commitment to the Hippocratic profanity and continuing, where clinical need presents, to enjoin coproxamol to their patients.
On the even so day under another article Russ McLean wrote January15 2008
I am appalled. Sir Alasdair Breckenridge, chair of the MHRA promised a safety net for the 70,000 UK patients* such as myself that allowance a clinical need for coproxamol after MA withdrawal on 31st December 2007.
to save the quondam two years, I possess had the full range of conjectural alternate analgesia and been hospitalised twice. All alternates proving either too strong, too fragile or with intolerable side effects.
serene more frustrating, is that following spinal surgery in 1994, I was talented to sign off of Higher Rate powerlessness Benefit and take up again a pregnant working spirit (creating 70 jobs over ten years). conditions through this MHRA muddle, I am faced with unmanaged confirmed pain and workless disablement because the MHRA "named tolerant" set-up is being shunned by doctors, my own included.
Today in Pulse, we have what seems like MHRA "revolve" from one end to the other cost sooner than patient attention, in another striving to again screw up the lives of thousands of patients who had effective pain managing by way of coproxamol.
Shame on those in the MHRA who have ignored not one but two House of Commons debates and hundreds of letters of disquiet from elder surgeons, doctors, heads of travail management clinics, charities etc. * 70,000 as per auditorium of Commons Debate - http://www.theyworkforyou.com/whall/?id=2007-01-17b.340.0
The background
· January 2005 – MHRA announces withdrawal of coproxamol
· October 2006 – A beat survey reveals 70% of GPs demand the MHRA analysis its decision
· January 2007 – MPs request u-mutiny on withdrawal at prominent legislative body of Commons dispute
· October 2007 – 60,000 patients remainder on coproxamol
· December 2007 – ultimate withdrawal of coproxamol
· January 2008 – PCTs frightened as cost out of coproxamol soars